Yahoo Web Search

Search results

  1. 4 hours ago · Eli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually make more doses of its popular weight-loss and diabetes treatments, Zepbound and Mounjaro. The ...

  2. 5 days ago · In 2023, Lilly began marketing and prescribing Zepbound, an injectable medication for adults with obesity and weight-related medical issues. Lilly was founded in 1876 and became a publicly traded company in 1952. As of 2023, the Indianapolis-based company employs more than 42,900 employees worldwide. Founding, early success, and growth

  3. 3 days ago · Nearly one-half of patients on mirikizumab achieved endoscopic response at 52 weeks; most of these patients were also in clinical remission. INDIANAPOLIS, May 21, 2024 /PRNewswire/ -- In Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active Crohn's disease, with or without previous biologic failure, achieved statistically significant and ...

  4. 3 days ago · China gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will intensify the drugmaker’s rivalry with Novo Nordisk A/S over weight ...

  5. 3 days ago · 0:04. 0:51. Eli Lilly and Co., is working with Boston-based biotechnology company, Aktis Oncology, to develop cancer treatment, Aktis announced Tuesday. As a part of the deal between the two ...

  6. 3 days ago · Lilly on Tuesday reported that mirikizumab aced both co-primary endpoints and all major secondary endpoints after 1 year of testing in the phase 3 VIVID-1 trial in Crohn’s disease. Notably ...

  7. 3 days ago · Blockbuster drug Mounjaro. If you'd invested $10,000 in Eli Lilly stock five years ago, you would have $65,900 today. That's a gain worthy of a top growth player.Lilly managed to draw the ...

  1. People also search for